Infectious and bleeding complications in patients with glycogenosis Ib.

Clinical, hematologic, and immunologic findings were reviewed in 21 patients with glycogenosis Ib. Fifteen of the patients suffered from moderate to severe bacterial infections. Ten patients had excessive epistaxis or bleeding from surgical sites, and eight suffered oral and anal mucosal ulceration. Sixteen of 21 patients exhibited chronic neutropenia associated with abnormalities in myeloid maturation and decreases in the bone marrow storage and peripheral marginating pools. Diminished neutrophil motility was documented in 14 of 15 patients tested, and adherence was decreased in three patients studied. Neutrophil microbicidal activity, reduction of nitroblue tetrazolium, and ingestion were normal in all patients tested. Bleeding times were prolonged in five of eight patients, and results of platelet function studies were abnormal in five individuals. Excessive bleeding in patients with glycogenoses Ia and Ib are similar and may be secondary to the functional deficiency of glucose-6-phosphatase. However, neutropenia, neutrophil dysfunction, and the resulting infectious complications are specific for Ib disease and may be related to abnormal glucose-6-phosphate transport.

[1]  J. Muenzer,et al.  TREATMENT OF HYPERPHENYLALANINEMIA SECONDARY TO A DEFICIENCY OF BIOPTERIN WITH REDUCED PTERINS , 1984, Pediatric Research.

[2]  K. Narisawa,et al.  Glycogen Storage Disease Type 1b: Microsomal Glucose-6-Phosphatase System in Two Patients with Different Clinical Findings , 1983, Pediatric Research.

[3]  K. Narisawa,et al.  An adult case of type Ib glycogen-storage disease. Enzymatic and histochemical studies. , 1983, The New England journal of medicine.

[4]  D. Weisdorf,et al.  Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis , 1982 .

[5]  C. Smith,et al.  Recurrent infection in glycogenosis type Ib: abnormal neutrophil motility related to impaired redistribution of adhesion sites. , 1981, The Journal of infectious diseases.

[6]  A. Beaudet,et al.  Neutropenia and impaired neutrophil migration in type IB glycogen storage disease. , 1980, The Journal of pediatrics.

[7]  E. McCabe,et al.  Neutropenia in a patient with type IB glycogen storage disease: in vitro response to lithium chloride. , 1980, The Journal of pediatrics.

[8]  A. Beaudet,et al.  Type Ib glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the microsomal glucose-6-phosphatase system. , 1980, The Journal of biological chemistry.

[9]  L. Sann,et al.  In vivo evidence for defective activity of glucose-6-phosphatase in type IB glycogenosis. , 1980, The Journal of pediatrics.

[10]  C. Smith,et al.  Motility and adhesiveness in human neutrophils. Effects of chemotactic factors. , 1979, The Journal of clinical investigation.

[11]  K. Narisawa,et al.  A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system. , 1978, Biochemical and biophysical research communications.

[12]  W. J. Arion,et al.  Measurement of glucose 6-phosphate penetration into liver microsomes. Confirmation of substrate transport in the glucose-6-phosphatase system. , 1977, The Journal of biological chemistry.

[13]  E. R. Stiehm,et al.  Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. , 1977, Pediatrics.

[14]  R. Simmons,et al.  Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. , 1975, Journal of immunology.

[15]  A. Fauci,et al.  Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. , 1975, The Journal of clinical investigation.

[16]  H. Greene,et al.  Impaired platelet function in glucose-6-phosphatase deficiency. , 1974, The Journal of pediatrics.

[17]  E. Goetzl,et al.  Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. , 1974, The Journal of clinical investigation.

[18]  E. Salzman,et al.  Platelet dysfunction in glycogen storage disease type I. , 1973, Blood.

[19]  J. Ott,et al.  Platelet function and pyrophosphates in osteogenesis imperfecta. , 1972, Blood.

[20]  A. Mowat,et al.  A simplified method for the measurement of chemotaxis of polymorphonuclear leukocytes from human blood. , 1971, The Journal of laboratory and clinical medicine.

[21]  B. Senior,et al.  Studies of liver glycogenoses, with particular reference to the metabolism of intravenously administered glycerol. , 1968, The New England journal of medicine.

[22]  S. Karpatkin,et al.  Biochemical energetics of simulated platelet plug formation. Effect of thrombin, adenosine diphosphate, and epinephrine on intra- and extracellular adenine nucleotide kinetics. , 1968, The Journal of clinical investigation.

[23]  G. Donnell,et al.  THE HEMOSTATIC DEFECT IN GLYCOGEN STORAGE DISEASE, TYPE I , 1968, Acta paediatrica Scandinavica.

[24]  C. Williams.  Methods in Immunology and Immunochemistry , 1967 .

[25]  B. Carruthers.  Leukocyte motility. I. Method of study, normal variation, effect of physical alterations in environment, and effect of iodoacetate. , 1966, Canadian journal of physiology and pharmacology.

[26]  E. Salzman.  MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE. , 1963, The Journal of laboratory and clinical medicine.

[27]  M. Karnovsky.  Metabolic basis of phagocytic activity. , 1962, Physiological reviews.

[28]  A. Mauer,et al.  Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. , 1961, The Journal of clinical investigation.